Join Now

Author Archives: Natalie Themm

Renalytix Clinical Advisory Board Formed to Support Broadening Use of KidneyintelX.dkd

By Natalie Themm | Published August 3, 2023

World leading, multi-disciplinary experts advise on adoption of FDA authorized KidneyintelX.dkd across 14 million US patients with diabetes and chronic kidney disease

Posted in BioUtah News | Tagged | Comments Off on Renalytix Clinical Advisory Board Formed to Support Broadening Use of KidneyintelX.dkd

Merit Medical’s WRAPSODY™ Arteriovenous Access Efficacy (WAVE) Pivotal Study Completes Enrollment

By Natalie Themm | Published August 3, 2023

SOUTH JORDAN, Utah, Aug. 03, 2023 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced the completion of enrollment in its WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal study. Merit’s WAVE study is a prospective, randomized, controlled, multicenter study comparing the Merit WRAPSODY Cell-Impermeable Endoprosthesis […]

Posted in BioUtah News | Tagged | Comments Off on Merit Medical’s WRAPSODY™ Arteriovenous Access Efficacy (WAVE) Pivotal Study Completes Enrollment

Alucent Biomedical Wins FDA Approval for U.S. Clinical Study

By Natalie Themm | Published August 3, 2023

U.S. FDA Grants an Investigational Device Exemption for Trial Evaluating Novel AlucentNVS Technology

Posted in BioUtah News | Tagged | Comments Off on Alucent Biomedical Wins FDA Approval for U.S. Clinical Study

Quansys Biosciences and The Michael J. Fox Foundation Partner to Accelerate Parkinson’s Disease Research

By Natalie Themm | Published August 3, 2023

Quansys Biosciences and The Michael J. Fox Foundation, announced a strategic partnership to accelerate research into PD.

Posted in BioUtah News | Tagged | Comments Off on Quansys Biosciences and The Michael J. Fox Foundation Partner to Accelerate Parkinson’s Disease Research

Myriad Genetics Announces Inclusion of Breast Density to MyRisk® with RiskScore® Breast Cancer Risk Assessment

By Natalie Themm | Published July 27, 2023

RiskScore is the first validated risk model that includes breast density, personal/family history and genetic markers. This comprehensive model is expected to identify more patients that could benefit from a change in their breast care.

Posted in BioUtah News | Tagged | Comments Off on Myriad Genetics Announces Inclusion of Breast Density to MyRisk® with RiskScore® Breast Cancer Risk Assessment

BD Receives FDA 510(k) Clearance for Updated BD Alaris™ Infusion System

By Natalie Themm | Published July 27, 2023

BD Alaris™ Infusion System is the only modular and most comprehensive infusion system on the U.S. market that includes large volume pumps, syringe pumps, patient-controlled analgesia (PCA) pumps, respiratory monitoring, auto-identification, dose error reduction software and EMR interoperability BD Alaris™ Infusion System’s unique “One System” platform securely connects all patient modules to provide care teams […]

Posted in BioUtah News | Tagged | Comments Off on BD Receives FDA 510(k) Clearance for Updated BD Alaris™ Infusion System

Renalytix Announces Middle East Distribution Agreement with Vector Pharma

By Natalie Themm | Published July 27, 2023

Distribution agreement opens kidneyintelX.dkd testing to address early-stage kidney disease in region with one of the highest incidence rates for type 2 diabetes globally

Posted in BioUtah News | Tagged | Comments Off on Renalytix Announces Middle East Distribution Agreement with Vector Pharma

CancerVAX Reports Significant Progress on Universal Cancer Vaccine Development at UCLA

By Natalie Themm | Published June 29, 2023

Three separate teams of physician scientists at UCLA working on three different parts of the project have made significant progress and are ready to merge their work into a complete proof-of-concept vaccine construct

Posted in BioUtah News | Tagged | Comments Off on CancerVAX Reports Significant Progress on Universal Cancer Vaccine Development at UCLA

Ultradent Adds New Cordless Prophy Handpiece

By Natalie Themm | Published June 29, 2023

Ultradent Products, Inc. is announcing the addition of the Ultrapro™ Tx Cordless handpiece to its prestigious Ultrapro™ Tx prophylaxis family

Posted in BioUtah News | Tagged | Comments Off on Ultradent Adds New Cordless Prophy Handpiece

CLENE ANNOUNCES PUBLICATION OF PHASE 2 CNM-AU8® CLINICAL DATA FOR THE TREATMENT OF ALS IN LANCET’S ECLINICALMEDICINE

By Natalie Themm | Published June 29, 2023

Peer-reviewed publication includes data from the CNM-Au8 Phase 2 RESCUE-ALS trial and its open-label-extension, up to 120 weeks of patient follow-up

Posted in BioUtah News | Tagged | Comments Off on CLENE ANNOUNCES PUBLICATION OF PHASE 2 CNM-AU8® CLINICAL DATA FOR THE TREATMENT OF ALS IN LANCET’S ECLINICALMEDICINE

Recursion Celebrates Opening of Its Canadian Headquarters in Toronto with Government Officials and the Biotech Ecosystem

By Natalie Themm | Published June 29, 2023

Recursion Celebrates Opening of Its Canadian Headquarters in Toronto with Government Officials and the Biotech Ecosystem

Posted in BioUtah News | Tagged | Comments Off on Recursion Celebrates Opening of Its Canadian Headquarters in Toronto with Government Officials and the Biotech Ecosystem

Intermountain Health Opens New Outpatient Surgery Center on TOSH Campus in Murray

By Natalie Themm | Published June 29, 2023

Intermountain Health Opens New Outpatient Surgery Center on TOSH Campus in Murray

Posted in BioUtah News | Tagged | Comments Off on Intermountain Health Opens New Outpatient Surgery Center on TOSH Campus in Murray

A Special Thanks To Our Legacy and Platinum Elite Members